Interested in learning more about us?
Modern Tek News on KZSU, Stanford 90.1 FM
News about new Pharmaceuticals, 3D-Printed Drugs & Modern Drug Design
In this interview, Ms. Jennifer Zieverinck discussed how Spritam will help patients, when it will be available
and the future plans that Aprecia has for producing new 3-D Printed drugs that will target diseases that affect
the Central Nervous System. Ms. Zieverinck gave us an overview of how 3D-Printed drugs are manufactured
as well as how she expects that their manufacturing process will improve with time. Ms. Zieverinck mentioned
that 3D-printing of drugs is the beginning of a revolution in the way drugs will be manufactured in the future.
Ms. Zieverinck also pointed out that 3D-Printing of drugs is not personalized medicine, and that each drug
has to take time to be approved by the FDA.